Skip to main content
All lobbying filings

THE PETRIZZO GROUP, INC.

THE PETRIZZO GROUP, INC. filed a Q1 report for MEDICAL ALLEY ASSOCIATION on April 16, 2025, reporting $40,000 in lobbying income.

Lobbying for MEDICAL ALLEY ASSOCIATION · Advances the global leadership of Medical Alleys healthcare industry.

All filings by THE PETRIZZO GROUP, INC. · Everything MEDICAL ALLEY ASSOCIATION has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 16, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
Minnesota

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Health Issues

Advocating for expanded and equal access of telehealth use in healthcare -- Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act. Medicare Coverage of Innovative Technology (MCIT) - H.R. 1691, the Ensuring Patient Access to Critical Breakthrough Products Act. EtO Emissions Standards. PFAS regulation. Artificial intelligence regulation in healthcare, and the broader government. Pediatric rare disease priority review voucher program reauthorization.

Medicare/Medicaid

Advocating for expanded and equal access of telehealth use in healthcare Medicare Coverage of Innovative Technology (MCIT) - the Ensuring Patient Access to Critical Breakthrough Products Act.

Taxation/Internal Revenue Code

The American Innovation and Jobs Act; The American Innovation and R&D Competitiveness Act

 Bills named in this filing 1
  • H.R. 1691
    Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem